eMedicine Specialties > Emergency Medicine > Genitourinary

Urinary Tract Infection, Male

Author: David S Howes, MD, Residency Program Director, Professor of Medicine, Section of Emergency Medicine, University of Chicago/Pritzker School of Medicine
Coauthor(s): M Tyson Pillow, MD, Assistant Director of Medical Education, Ben Taub General Hospital Emergency Center; Assistant Professor, Baylor College of Medicine
Contributor Information and Disclosures

Updated: Apr 27, 2009

Introduction

Background

The consideration of male urinary tract infection (UTI) is complicated by the overlap with what might be termed reproductive tract infections. For the purposes of this article, the male UTI includes infections that arise from bacterial colonization of the urinary tract proper (ie, kidney, ureter, bladder). Infections of contiguous structures, for example, urethritis, epididymitis, prostatitis, or orchitis, are covered in other articles.

Pathophysiology

As with females, the usual route of inoculation in males is with gram-negative aerobic bacilli from the gut, with Escherichia coli being the most common offending organism. Bacterial cystitis in the male is uncommon in the absence of anatomic abnormality, defect in bladder emptying mechanism, or urethral catheterization. In the normal host, urinary tract infection (UTI) may occur due to infection of other portions of the genitourinary tract, typically the prostate. Older males with prostatic hypertrophy have incomplete bladder emptying, predisposing them to UTI on the basis of urinary stasis. However, in males aged 3 months to 50 years, incidence of UTI is low; therefore, the possibility of an anatomical abnormality must be entertained in this age group.

Frequency

United States

The frequency of male urinary tract infection (UTI) is related to age (see Age below).

International

In developed countries, the incidence of urinary tract infection in males is similar to that in the United States. However, in developing countries where men have shorter life spans, the incidence of urinary tract infection due to prostatic hypertrophy is lower.

Mortality/Morbidity

Otherwise healthy males without anatomical abnormality who promptly seek treatment experience little morbidity besides the discomfort of an infection.

  • In more complicated cases (eg, prolonged infection, anatomical variations), the sequelae of infection can be more significant. Complications include stricture secondary to inflammation within the urinary tract, abscess and fistula formation, bacteremia, and adverse effects on kidney function.
  • In elderly patients, UTI is a significant cause of morbidity and death, with the expected death rate as high as 3% in those who develop pyelonephritis. The high mortality rate is largely due to delayed presentation and the development of bacteremia/sepsis.

Sex

Although this article exclusively addresses urinary tract infection (UTI) in males, the clinician should appreciate that the incidence of UTI is much higher in females during adolescence and childbearing years. The incidence of UTI in men approaches that of women only in men older than 60 years.

Age

The incidence of urinary tract infection (UTI) has an early peak during the first 3 months of life. In neonates, a UTI occurs more frequently in boys than in girls (with a male-to-female ratio of 1.5:1), and it is often part of the syndrome of gram-negative sepsis.

  • The cumulative incidence of symptomatic UTI (including pyelonephritis) in boys during the first 10 years of life has been reported at 1.1-1.6%.
  • The incidence of true UTI in adult males younger than age 50 years is low (approximately 5-8 per year per 10,000). In this population, the symptoms of dysuria or urinary frequency are usually due to sexually transmitted disease (STD)–related infections of the urethra (eg, gonococcal and nongonococcal urethritis) and prostate.1
  • In men older than 50 years, the incidence of UTI rises dramatically (anywhere from 20-50% prevalence) because of enlargement of the prostate, prostatism, debilitation, and subsequent instrumentation of the urinary tract.

Clinical

History

  • The most frequent chief complaint with urinary tract infection (UTI) is dysuria.
  • Other aspects to inquire about include urgency, frequency, nocturia, gross hematuria, and any changes in the color and/or consistency of the urine.
  • Associated signs and symptoms include fever, chills, back/flank pain, suprapubic pain, and nausea and vomiting.
  • Ask elderly men about a history of prior UTI, prostatic enlargement, urinary dribbling or hesitancy, or difficulty initiating the urinary stream.
  • Ask all men about known urinary tract abnormalities, personally and within their families, as well as any history of prior UTI.
  • Particularly in elderly patients, inquire about prior urinary tract manipulation, history of indwelling catheters, or other chronic urinary tract problems; these patients are at much higher risk of UTI.
  • Urethral catheterization appear to be the highest risk of UTI with 10-30% developing UTI and a 3-10% daily incidence of bacteruria. The significance of bacteruria or colonization in patients with indwelling catheters, however, is debated in the literature as very few go on to develop bacteremia/sepsis.
  • Other relevant items in the history include comorbid conditions (eg, diabetes), HIV status, immunosuppressive treatments for other conditions (eg, prednisone), and any prior surgeries or instrumentation involving the urinary tract.
  • One of the difficulties in diagnosing UTI in males lies in the fact that dysuria, with or without discharge, is the typical chief complaint with urethritis, which is a much more common disease. Determining the history of urinary and genital tract symptoms and sexual encounters, combined with laboratory testing of urine and urethral swabs, should allow differentiation of the two.
  • Classic findings with pyelonephritis include fever, chills, and costovertebral angle (CVA) tenderness that follow the symptoms of UTI. Note that 30-50% of pyelonephritis cases may be silent, without clinical symptoms.
    • In the older male, prostate enlargement along with delayed presentation are the primary causes of pyelonephritis.
    • Other historical risk factors include nephrolithiasis, neurogenic bladder, prostatitis, or symptom duration greater than 5 days.
  • In a younger man, the presence of UTI is often associated with a history of anatomical abnormality. In the absence of this history, a detailed sexual history may implicate activities such as a new sex partner, multiple sex partners, and other risk-taking behavior associated with STD-related urethritis, prostatitis, or epididymitis that may lead to UTI.  

Physical

Physical findings of urinary tract infection may include the following:

  • Fever
  • Tachycardia
  • Costovertebral angle (CVA) tenderness (bruits)
  • Abdominal tenderness in the suprapubic area and guarding (A pulsatile mass in the elderly patient suggests possible abdominal aortic emergency.)
  • Scrotal hematoma, hydrocele, masses, or tenderness
  • Meatal discharge
  • Rectal lesions or abscesses
  • Prostatic tenderness or hypertrophy
  • Inguinal adenopathy

Causes

  • Urinary tract infection (UTI) in males is typically caused by bacterial colonization of the urinary tract, though fungal or other types of infection are possible.
  • The sources of these bacteria or other agents can vary. Routes of infection include the following:
    • Direct ascension up the urinary tract via the urethra
    • Hematogenous spread, as with bacteremia
    • Spreading from contiguous structures, such as the prostate
    • Iatrogenic instrumentation

More on Urinary Tract Infection, Male

Overview: Urinary Tract Infection, Male
Differential Diagnoses & Workup: Urinary Tract Infection, Male
Treatment & Medication: Urinary Tract Infection, Male
Follow-up: Urinary Tract Infection, Male
References
Further Reading

References

  1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. Jul 8 2002;113 Suppl 1A:5S-13S. [Medline].

  2. Johnson JR. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. Sep 15 2004;39(6):873; author reply 873-4. [Medline].

  3. Daunt SW. Accuracy of ultrasonography and plain-film abdominal radiography in the diagnosis of urologic abnormalities in men with urinary tract infection: critically appraised topic. Can Assoc Radiol J. Feb 2004;55(1):16-7. [Medline].

  4. Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother. Jul-Aug 2004;38(7-8):1148-52. [Medline].

  5. Anandkumar H, Kapur I, Dayanand A. Increasing prevalence of antibiotic resistance and multi drug resistance among uropathogens. J Commun Dis. Jun 2003;35(2):102-8. [Medline].

  6. Ginde AA, Rhee SH, Katz ED. Predictors of outcome in geriatric patients with urinary tract infections. J Emerg Med. Aug 2004;27(2):101-8. [Medline].

  7. Griebling TL. Urologic diseases in america project: trends in resource use for urinary tract infections in men. J Urol. Apr 2005;173(4):1288-94. [Medline].

  8. Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68(9):1169-205. [Medline].

  9. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am. Jun 2003;17(2):303-32. [Medline].

  10. Howes DS, Bogner MP. Urinary tract infections. In: Tintinalli JE et al, eds. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York, NY: McGraw-Hill; 2004:606-612.

  11. Hummers-Pradier E, Ohse AM, Koch M, et al. Urinary tract infection in men. Int J Clin Pharmacol Ther. Jul 2004;42(7):360-6. [Medline].

  12. Sanford JP. Guide to Antimicrobial Therapy. Dallas, Tex: Antimicrobial Therapy Inc; 2008.

  13. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis. Nov 1 2008;47(9):1150-8. [Medline].

  14. Thompson PDR. Physicians' Desk Reference. 2008.

  15. Weir M, Brien J. Adolescent urinary tract infections. Adolesc Med. Jun 2000;11(2):293-313. [Medline].

  16. Wells WG, Woods GL, Jiang Q, Gesser RM. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. J Antimicrob Chemother. Jun 2004;53 Suppl 2:ii67-74. [Medline].

Further Reading

Clinical guidelines

Prevention of catheter-associated urinary tract infections. In: Prevention and control of healthcare-associated infections in Massachusetts. Prevention of catheter-associated urinary tract infections. In: Betsy Lehman Center for Patient Safety and Medical Error Reduction, JSI Research and Training Institute, Inc. Prevention and control of healthcare-associated infections in Massachusetts. Part 1: final recommendations of the Expert Panel. Boston (MA): Massachusetts Department of Public Health; 2008 Jan 31. p. 83-9.

Keywords

urinary tract infection men, UTI, cystitis, pyelonephritis, Escherichia coli infection, gonococcal urethritis, nongonococcal urethritis, prostatitis, epididymitis, orchitis, dysuria, urgency, frequency, nocturia, hematuria, prostatic enlargement, urinary dribbling, urinary hesitancy, indwelling catheter, Foley catheter, nephrolithiasis, neurogenic bladder, meatal discharge, scrotal hematoma, hydrocele, costovertebral angle tenderness, CVA tenderness, prostatic tenderness, prostatic hypertrophy

Contributor Information and Disclosures

Author

David S Howes, MD, Residency Program Director, Professor of Medicine, Section of Emergency Medicine, University of Chicago/Pritzker School of Medicine
David S Howes, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

M Tyson Pillow, MD, Assistant Director of Medical Education, Ben Taub General Hospital Emergency Center; Assistant Professor, Baylor College of Medicine
M Tyson Pillow, MD is a member of the following medical societies: Air Medical Physician Association, American College of Emergency Physicians, American Medical Association, American Medical Student Association/Foundation, Emergency Medicine Residents Association, Society for Academic Emergency Medicine, and Student National Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Joseph A Salomone III, MD, EMS Medical Director, Kansas City, Missouri; Associate Professor and Staff Physician, Truman Medical Centers/UMKC School of Medicine
Joseph A Salomone III, MD is a member of the following medical societies: American Academy of Emergency Medicine, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard H Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School
Jonathan Adler, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.